Hui Wang

发表

Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors

Bing-he Xu, Yilong Wu, L. Shen, 2011, Journal of hematology & oncology.

A longitudinal follow-up of COVID-19 patients in the convalescent phase showed recovery in radiological results, the dynamics of lymphocytes, and a decrease in the level of IgG antibody: a single-centre, observational study

Hui Wang, Xiaoju Zhang, Zhiwei Xu, 2021, Journal of thoracic disease.

Combination of Anlotinib and Celecoxib for the Treatment of Abdominal Desmoid Tumor: A Case Report and Literature Review

Hui Wang, Shuiping Tu, C. Nie, 2022, Frontiers in Oncology.

TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 Study

Huyuan Yang, Y. Bang, Chia‐Chi Lin, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

Personalized Treatment of Advanced Gastric Cancer Guided by the MiniPDX Model

Hui Wang, Shuiping Tu, C. Nie, 2022, Journal of oncology.

Cancer stage-dependent alterations in cell-free DNA in patients with colorectal cancer.

Hui Wang, C. Xing, Wei Gong, 2021, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

NTRK fusion positive colorectal cancer as a unique subset of CRC with high tumor mutation burden and microsatellite instability.

S. Ou, Hui Wang, Xue Wu, 2021 .

Treatment strategies for hormone receptor-positive, human epidermal growth factor receptor 2-positive (HR+/HER2+) metastatic breast cancer: A review

Hui Wang, Jin Yang, Jiao Yang, 2022, Frontiers in Oncology.

Abstract PD1-08: Oral paclitaxel and encequidar (oPac+E) versus IV paclitaxel (IVPac) in the treatment of metastatic breast cancer (mBC) patients (study KX-ORAX-001): Progression free survival (PFS) and overall survival (OS) updates

H. Rugo, Hui Wang, D. Cutler, 2021 .

Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: an open-label phase 1b study

Xu Zhang, F. Zhou, Yinghao Sun, 2013, BMC Cancer.

Gls-010, a novel anti-PD-1 mAb in Chinese advanced gastrointestinal tumor: Result of a phase Ib clinical trial.

Z. Liu, Yingying Xu, Hui Wang, 2019, Journal of Clinical Oncology.

Pharmacokinetic evaluation of novel oral fluorouracil antitumor drug S-1 in Chinese cancer patients

Hong Zhang, Hui Wang, Hong Zhu, 2013, Acta Pharmacologica Sinica.

Pharmacokinetic study of vinorelbine in Chinese patients with non-small-cell lung cancer by high- performance liquid chromatography (HPLC) with fluorescence detection

Hui Wang, Yuchao Dong, H. Xin, 2013 .

Phase II study of FGFR1-3 inhibitor tinengotinib as monotherapy in patients with advanced or metastatic cholangiocarcinoma: Interim analysis.

Hui Wang, Q. Ru, Jean Fan, 2023, Journal of Clinical Oncology.

Effect of the weekly administration of liposome-Paclitaxel combined with s-1 on advanced gastric cancer.

Hui Wang, Xudong Shen, Qiang Chen, 2014, Japanese journal of clinical oncology.